A Double-Blind, Placebo-Controlled, Single-Dose Escalation and Food Effect Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ONO-6950 in Healthy Adult Subjects.

Trial Profile

A Double-Blind, Placebo-Controlled, Single-Dose Escalation and Food Effect Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ONO-6950 in Healthy Adult Subjects.

Completed
Phase of Trial: Phase I

Latest Information Update: 12 Jun 2012

At a glance

  • Drugs Gemilukast (Primary)
  • Indications Asthma
  • Focus Adverse reactions
  • Most Recent Events

    • 30 Jun 2011 Actual end date (Jun 2011) added as reported by ClinicalTrials.gov.
    • 30 Jun 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 23 Feb 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top